4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000006
CFO AND TREASURER sold 21,000 shares at an average $470.36 ($9,877,535)
- CFO AND TREASURER acquired 21,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,688 | $146.03 | $1,560,769 | 18,806 | D |
| 2025-11-17 | Sale : show line 2 in the form 10b5-1 | −3,591 | $470.34 | $1,688,978 | 15,215 | D |
| 2025-11-17 | Sale : show line 3 in the form 10b5-1 | −2,657 | $471.22 | $1,252,030 | 12,558 | D |
| 2025-11-17 | Sale : show line 4 in the form 10b5-1 | −1,999 | $472.13 | $943,786 | 10,559 | D |
| 2025-11-17 | Sale : show line 5 in the form 10b5-1 | −920 | $473.68 | $435,783 | 9,639 | D |
| 2025-11-17 | Sale : show line 6 in the form 10b5-1 | −639 | $474.80 | $303,397 | 9,000 | D |
| 2025-11-17 | Sale : show line 7 in the form 10b5-1 | −798 | $475.89 | $379,761 | 8,202 | D |
| 2025-11-17 | Sale : show line 8 in the form 10b5-1 | −84 | $476.47 | $40,024 | 8,118 | D |
| Open-market sales · 21,000 sh · avg $470.36 · $9,877,535 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-11-17 | Exercise or conversion : show line 15 in the form 10b5-1 Stock Option | −10,312 | $146.03 | 2027-03-15 | 10,312 | 0 | D |
| 2025-11-17 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option | −10,688 | $146.03 | 2027-03-15 | 10,688 | 21,517 | D |
Loading xslF345X05/primarydocument.xml…